1981
DOI: 10.1016/0026-0495(81)90035-4
|View full text |Cite
|
Sign up to set email alerts
|

Insulin binding and action in isolated rat hepatocytes: Evidence for spare receptors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
12
0

Year Published

1983
1983
2013
2013

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 23 publications
(13 citation statements)
references
References 27 publications
1
12
0
Order By: Relevance
“…There was no accumulation of glycogen in these cells during incubation in agreement with other reports studying hepatocytes incubated with glucose [23][24][25].…”
Section: Discussionsupporting
confidence: 93%
See 2 more Smart Citations
“…There was no accumulation of glycogen in these cells during incubation in agreement with other reports studying hepatocytes incubated with glucose [23][24][25].…”
Section: Discussionsupporting
confidence: 93%
“…The former denotes impaired sensitivity and the latter decreased responsiveness to insulin [27]. Since hepatocytes have spare insulin receptors [23], the diminished capacity of the high affinity, low capacity receptor can explain the impaired sensitivity. The decreased responsiveness is due to a post-receptor defect [27].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Still, the content of IR in cells can impact insulin signal transduction and the biological response to insulin. Previously, the recognition that the maximal response to insulin was elicited under conditions of less than complete IR binding (occupancy) led to a "spare receptor theory" [16]. While some investigators have postulated that with spare IR, moderate changes in IR number or even function might not impact insulin action, the studies of IR knockout mice described above demonstrate that a reduction in tissue IR content has a significant physiological impact.…”
Section: Physiological Regulation Of the Irmentioning
confidence: 96%
“…Since these receptor types may have different levels of functional significance, larger affinity variations in those receptor types of lesser concern (often the low affinity receptors) could be acceptable. Additionally, some biopharmaceuticals (e.g., insulin and leutinizing hormone (Frank et al, 1981;Mendelson et al, 1975)) have spare receptors (i.e., receptors which exist in excess of those required to produce a maximal PD effect (Bourne and von Zastrow, 2004). Binding affinity differences for these products may pose less of a concern if biopharmaceutical target occupancy is suitable to induce a comparable pharmacological response.…”
Section: Defining a Pharmacologically Relevant Speciesmentioning
confidence: 99%